LABOLIFE 2LINFLAM

More info

The main objective of Labo'Life's medications is the patient's immune recovery. To achieve this, they use molecules specific to the immune system, obtained through biotechnology techniques, under strict quality control, and always complying with Good Manufacturing Practices (GMP).

Micro-Immunotherapy medications include:
Immunocompetent substances: cytokines, chemokines, growth factors, etc.
General nucleic acids (RNA, DNA).
Pathology-specific nucleic acids (SNA®): substances that represent a significant therapeutic innovation and with which Labo'Life, the first laboratory to integrate them into its formulas, has extensive experience.

Due to their characteristics, Micro-Immunotherapy treatments can be integrated into any therapeutic strategy and have a wide range of applications.

Formula: Composition corresponding to a sequence of 10 capsules:
Interleukin 1 (IL-1):
Interleukin 1 Receptor Antagonist (IL-1 Ra): Interleukin 2 (IL-2):
Interleukin 4 (IL-4):
Interleukin 6 (IL-6):
Interleukin 8 (IL-8):
Interleukin 10 (IL-10):
Interleukin 13 (IL-13):
Ciliary Neurotrophic Factor (CNTF):
Leukemia Inhibitory Factor (LIF):
Oncostatin M (OSM):
Platelet Derived Growth Factor (PDGF): Prostaglandin E2 (PGE2):
Rantes:
Transforming Growth Factor Beta (TGF-β): Tumor Necrosis Factor Alpha (TNF-α):
Specific Nucleic Acid SNA®-INFLAMa-01: Specific Nucleic Acid SNA®-INFLAMb-01: Excipient: lactose, sucrose per gelatin capsule

Do you like this product?